首页 | 本学科首页   官方微博 | 高级检索  
     

新型抗真菌药物在眼科的研究进展
引用本文:陈祖基. 新型抗真菌药物在眼科的研究进展[J]. 眼科研究, 2007, 25(8): 629-633
作者姓名:陈祖基
作者单位:450003,郑州,河南省眼科研究所,河南省眼科中心
摘    要:近年来,一些新的抗真菌药物相继问世,包括新三唑类(活力康唑、泊沙康唑等)和棘白菌素类(卡泊芬净、米卡芬净等)。这些药物具有更广的抗真菌谱,提供了更好的抗真菌活性。这些新的抗真菌药物在初步的眼科临床实践中已显示出良好的应用前景。兹就新型抗真菌药物在眼科临床研究的最新进展做一综述。

关 键 词:新三唑类  棘白菌素类  活力康唑  泊沙康唑  卡泊芬净  米卡芬净
文章编号:1003-0808(2007)08-0629-05
修稿时间:2007-05-30

Research progress in novel antifungal drugs in ophthalmology
Chen Zuji. Research progress in novel antifungal drugs in ophthalmology[J]. Chinese Ophthalmic Research, 2007, 25(8): 629-633
Authors:Chen Zuji
Affiliation:Henan Institute of Ophthalmology, Zhengzhou 450003, China
Abstract:In recent years,some novel antifungal agents have been developed,including new azoles such as vorriconazole and posaconazole, and echinocandins such as caspofungin and micafungin. These novel antifungal agents present a broader antifungal spectrum and a more effective antifungal activity. They also have shown a good prospect in the preliminary ophthalmic clinical practice. This review summarizes the current advance in clinical use in ophthalmology of novel antifungal agents.
Keywords:new azoles   echinocandins   vorriconazole   posaconazole   caspofungin   micafungin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号